The National Clinical Evidence Taskforce is a multi-disciplinary collaboration of 35 member organisations – Australia’s medical colleges and peak health organisations – who share a commitment to provide national evidence-based treatment guidelines for urgent and emerging diseases.
This pioneering alliance established the world’s first ‘living guidelines’ for the care of people with COVID-19 and the scope has now expanded to include MPX.
The Taskforce undertakes continuous evidence surveillance to identify and rapidly synthesise emerging research to develop and update recommendations to ensure Australian clinicians are up-to-date with the latest advice.
Evidence summaries for relevant diseases in Australia
Your views help us to identify and prioritise questions to include in the living guideline.
Submit your questions here
Subscribe here to receive regular updates from the Taskforce
